Results 61 to 70 of about 4,927,702 (244)

Changes in the incidence, viral coinfection pattern and outcomes of pneumococcal hospitalizations during and after the COVID-19 pandemic

Pneumonia
Background The incidence of pneumococcal pneumonia in the context of the Coronavirus Disease 2019 (COVID-19) pandemic, along with the real-world data on the ratio of non-invasive to invasive pneumococcal pneumonia, is an area that has not been thoroughly
King-Pui Florence Chan, Ting-Fung Ma, Hanshu Fang, Wai-Kai Tsui, James Chung-Man Ho, Mary Sau-Man Ip, Pak-Leung Ho   +6 more
doaj   +1 more source

Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development [version 2; peer review: 2 approved]

F1000Research, 2023
Pneumococcal disease is a global public health concern as it affects the young, aged and the immunocompromised. The development of pneumococcal vaccines and their incorporation in the immunization programs has helped to reduce the global burden of ...
Ahmed H. Radhi, Delan Ikram, Haider N. Dawood, Ali H. Al-Jumaili, Ali Al-Jabban   +4 more
doaj   +1 more source

Variation in blood culture testing in children hospitalized with three common infections

Journal of Hospital Medicine, EarlyView.
Abstract Background Routine blood culture (BCx) testing in uncomplicated community‐acquired pneumonia (CAP), skin and soft tissue infections (SSTI), and urinary tract infections (UTI) has demonstrated low clinical utility. Objectives To evaluate hospital‐level BCx testing trends and their association with clinical outcomes for children hospitalized ...
Smit Shah, Jennifer L. Goldman, Matt Hall, John R. Stephens, Jillian M. Cotter, Samantha A. House, Matthew J. Molloy, Michelle Polich, Michael J. Steiner, Michael J. Tchou, Ronald J. Teufel II, Irma T. Ugalde, Andrew G. Yu, Jessica L. Markham   +13 more
wiley   +1 more source

Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. [PDF]

, 2011
OBJECTIVE: To document trends in invasive pneumococcal disease (IPD) in a central hospital in Malawi during the period of national scale-up of antiretroviral therapy (ART) and cotrimoxazole prophylaxis.
Mavuto Mukaka, Gordon, Stephen, French Neil, Molyneux, Malcolm, Stephen B Gordon, Neil French, van Oosterhout Joep J., Denis, Brigitte, French, Neil, Brigitte Denis, Malcolm Molyneux, Molyneux, Elizabeth M, Robert S. Heyderman, Carrol, Enitan D., Elizabeth M Molyneux, Molyneux, Elizabeth M., Mukaka, Mavuto, Joep J van Oosterhout, Heyderman Robert S., Robert S Heyderman, Dean B Everett, van Oosterhout, Joep J, Everett Dean B., Gordon Stephen B., Carrol, Enitan D, Molyneux Malcolm, Dean B. Everett, Enitan D. Carrol, Gordon, Stephen B, Mukaka Mavuto, van Oosterhout, Joep J., Elizabeth M. Molyneux, Denis Brigitte, Stephen B. Gordon, Joep J. van Oosterhout, Heyderman, Robert S., Everett, Dean B, Heyderman, Robert S, Everett, Dean B., Molyneux Elizabeth M., Carrol Enitan D., Enitan D Carrol   +41 more
core   +2 more sources

Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study

The Lancet Public Health
Summary: Background: Paediatric pneumococcal conjugate vaccine (PCV) programmes in England using seven-valent PCV (PCV7) in 2006 and 13-valent PCV (PCV13) in 2010 have reduced vaccine-type invasive pneumococcal disease, but the overall effect has been ...
Yoon Hong Choi, PhD, Marta Bertran, MSc, David J Litt, PhD, Shamez N Ladhani, ProfPhD, Elizabeth Miller, ProfFMedSci   +4 more
doaj   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +1 more source

Vaccination in pediatric transplantation—General recommendations. A position paper by the European Reference Network TransplantChild

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Infectious diseases remain a leading cause of morbidity and mortality among pediatric transplant recipients, despite significant advances in transplantation management. Vaccination is the most effective strategy to prevent infections; however, its efficacy is hindered in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT)
Valeria Casotti, Francesco Saglio, Adriana Balduzzi, Peter Barany, Vibeke Brix Christensen, Simona Buelli, Daniele Donà, Maja Klaudel‐Dreszler, Sara Mosca, Andrea Pietrobattista, Michele Pinon, Giusy Ranucci, Lars Wennberg, Lorenzo D'Antiga, ERN TransplantChild Working Group, Claudia Vittori, Manuela Tumino, B. Ruben Brandsema, Lisa Swartling, Silvia Garazzino, Carlo Pace Napoleone, Kai Lehmberg, Isabella Guzzo, Charlotte Roy, Nicola Pradegan, Silvia Simo Nebot, Maria Herthelius, Angelo Mazza, Enrico Aidala, Oleg Godik, Victoria Bordon Cueto De Braem, Marco Busutti, Emily Claire Argento, Marc Garcia Lorenzo, Timo Jahnukainen, Zoryana Ivanyuk   +35 more
wiley   +1 more source

Burden of Invasive Pneumococcal Disease

Clinical Infectious Diseases, 2019
TO THE EDITOR—We read with interest the article by Kent et al [1]. The authors note that the burden of invasive pneumococcal disease (IPD) in UK infants aged
Slack, Mary, Vyse, Andrew, Madhava, Harish, Ellsbury, Gillian, Czudek, Carole, Reinert, Ralf-Rene, Gessner, Bradford   +6 more
openaire   +3 more sources

Refractory Eczema as a Presenting Feature of Common Variable Immunodeficiency

JEADV Clinical Practice, EarlyView.
ABSTRACT Common variable immunodeficiency (CVID) is the most prevalent symptomatic inborn error of immunity (IEI) in adults. It presents with recurrent infections and non‐infectious complications, including autoimmunity, lymphoproliferation and dermatitis.
Mercedes Sanchez‐Diaz, Lars Matthies, Andrea Vanegas Ramirez   +2 more
wiley   +1 more source

Pneumococcal disease in the Arabian Gulf: Recognizing the challenge and moving toward a solution

Journal of Infection and Public Health, 2013
Summary: Pneumococcal disease has substantial incidence, morbidity and mortality in older adults. Decreased birth rates and longer lifespans indicate that the global population is aging, although rates of aging differ between countries [1].
Charles Feldman, Emad Abdulkarim, Fatma Alattar, Faryal Al Lawati, Hisham Al Khatib, Muna Al Maslamani, Idris Al Obaidani, Mosaab Al Salah, Mohamed Farghaly, Entesar H. Husain, Eiman Mokadas   +10 more
doaj   +1 more source